| Comprehensive Solid Tumor Panel |
450+ genes |
FFPE, Blood |
Advanced solid tumors, precision oncology |
14-21 days |
| Hematologic Malignancy Panel |
200+ genes |
Blood, Bone Marrow |
Leukemia, lymphoma, myeloma |
14-21 days |
| Lung Cancer Panel |
EGFR, ALK, ROS1, KRAS, BRAF, MET + 50 more |
FFPE, Plasma |
NSCLC, SCLC, targeted therapy selection |
7-14 days |
| Breast/Ovarian Cancer Panel |
BRCA1/2, PALB2, TP53, + 30 more |
Blood, FFPE |
Hereditary cancer, PARP inhibitor eligibility |
10-14 days |
| Liquid Biopsy (ctDNA) |
70+ actionable genes |
Plasma |
Early detection, treatment monitoring, MRD |
14-21 days |
| Hereditary Cancer Panel |
80+ cancer predisposition genes |
Blood |
Family history of cancer, genetic counseling |
21-28 days |